Drug adherence amongst tuberculosis patients in the university of ilorin teaching hospital, ilorin, nigeria

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 3, 2010, Pages 109-114

  Bello, S I ^a   Itiola, O A ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Drug adherence; Ilorin; Nigeria; Patients; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; EYE JAUNDICE; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA AND VOMITING; NIGERIA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; SEX RATIO; SHORT COURSE THERAPY; SIDE EFFECT; TEACHING HOSPITAL; TERTIARY HEALTH CARE; TREATMENT DURATION; URINE; VISUAL IMPAIRMENT;

EID: 77951161291     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Adair R, Nwarneri O, Barnes N (1999). Health care access for Somali refugees. View of patients, doctors, nurses. Am. J. Health Behav. 4: 286-293.
2. Aktogu S, Yorgancioglu A, Cirak K, Kose T, Dereli SM (1998). Clinical spectrum of pulmonary and pleural tuberculosis; A report of 480 cases. Eur Respir. J. 5: 2031-2025.
3. Ashry G, Ahmed MA, Mandil A, Sherif ZAR, Gad M, Sunny S (1997). Compliance with anti-tuberculosis drugs among tuberculosis patients. Eastern Mediterranean Health J. 3(2): 244-250.
4. Atul SP, Mehrotra P, Dhar HI (2004). Assessment of pulmonary tuberculosis in patients. Bombay Hosp. J. 46(2): 1-7.
5. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN (2002). Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 10: 45-52.
6. Blenkiron P (1996). The elderly and their medication: Understanding and compliance in family practice. Postgrad. Med. J. 72: 667-6.
7. Borgdorff MW, Flalo K, Broekmans JF (2002). Interventions to reduce tuberculosis mortality and transmission in low and middle-income countries. Bulletin of the WHO (80): 217-226.
8. Cantwell MF, Snider DE Jr, Cauthen GM (1994). Epidemiology of tuberculosis in the United States, JAMA. 272(7): 535-539.
9. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999). Consensus statement. global burden of tuberculosis; Estimated incidence, prevalence and immortality by country. WHOs Global Surveillance and Monitoring Project. JAMA. 282: 677-686.
10. Fakeye TO, Itiola OA, Akindele OO (1997) Drug utilization in a University Community. Nig Qt. J. Hosp. Med. 1.7: 3.
11. Genstat (1995). Genstat 5 release 3.2. Reference manual supplement. Clarendon Press, Oxford, U.K.
12. Hamburg MA, Frieden TR (1994). Tuberculosis transmission in 1990's (ed). New England J. Med. 330: 1750.
13. Ige OM, Sogaolu OM, Ogunlade OA (2005). Pattern of presentation of tuberculosis and the hospital prevalence of tuberculosis and HIV co-infection in University College Hospital: A review of five years (1998-2002) in Afr. J. Med. Med. Sci. 34(3): 29-33.
14. Iseman MD (1993). Treatment of multidrug-resistant tuberculosis. New England J. Med. 329(11): 784-791.
15. Kehinde AO, Olaniyi JA, Fakunle EE (2006). Extra pulmonary tuberculosis in sickle cell disease. Afr. J. Med. Med. Sci. 35: 381-384.
16. Kyngas H, Lahdenpeia T (1999). Compliance of patients with drugs and associated factors. 4: 823-829.
17. Morisky DE, Nyamathi A, Sneed CD, Liu KY (1998). Health education improves tuberculosis control. Gateway to the National of Medicine. Mar. pp. 8-11.
18. Mousa KL, Drousa, FG, Faragay SA (1995). Smear-positive pulmonary tuberculosis; preliminary results of a study in Alexandria and Menoufia, Egypt, 1993. Paper presented at the international epidemiogical association EMR meeting, Alexandria Egypt 9: 1-4.
19. Sullivan SD, Kreling DH, Hazlet TK (1990). Non-compliance with medication regimes and subsequent hospitalization: A literature, analysis and costs of hospitalization estimates. J. Res. Pharmaceut. Econ. 2: 19-33.
20. Walls T, Shingadia D (2004). Global epidemiology of pediatric tuberculosis. J. Infect. 48: 13-22.
21. World Health Organization (2001). Global tuberculosis control. World Health Organization, Geneva, Switzerland.
22. World Health Organization (2004). Report of global tuberculosis control: Surveillance, planning and financing. World Health Organization, Geneva, Switzerland.
23. th Annual Inter-science Conference on Antimicrobial Agents and chemotherapy, Washington DC.